Inflammatory and endothelial dysfunction markers and proteinuria in persons with type 1 diabetes mellitus
- PMID: 20332124
- PMCID: PMC2921795
- DOI: 10.1530/EJE-10-0049
Inflammatory and endothelial dysfunction markers and proteinuria in persons with type 1 diabetes mellitus
Abstract
Objective: We examined the relationship of inflammatory and endothelial dysfunction markers with the prevalence and incidence of gross proteinuria (GP) in persons with type 1 diabetes mellitus.
Design: A longitudinal population-based cohort of persons with type 1 diabetes mellitus was followed from 1990-1992 through 2005-2007.
Methods: Prevalence and 15-year cumulative incidence of GP were defined as outcome variables. Serum high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), soluble vascular cell adhesion molecule-1 (VCAM-1), soluble intercellular adhesion molecule-1, and serum total homocysteine were measured. Multivariate logistic and discrete linear logistic regression modeling was used for data analysis.
Results: After controlling for duration of diabetes and other confounding factors, TNF-alpha (odds ratio (OR) 3.64; 95% confidence interval (CI) 2.33, 5.70), IL-6 (OR 1.41; 95% CI 1.06, 1.88), VCAM-1 (OR 13.35; 95% CI 5.39, 33.07), and homocysteine (OR 2.98; 95% CI 1.73, 5.16) were associated with prevalent proteinuria. Only hsCRP (OR 1.47; 95% CI 1.02, 2.11) was associated with incident proteinuria.
Conclusions: These findings suggest a role of inflammation and endothelial dysfunction as markers and contributors of the development of diabetic nephropathy in persons with type 1 diabetes mellitus.
References
-
- Parving HH, Hovind P, Rossing K, Andersen S. Evolving strategies for renoprotection: diabetic nephropathy. Current Opinion in Nephrology and Hypertension. 2001;10:515–522. - PubMed
-
- Krempf M. Specifics of diabetic nephropathy, viewpoint in diabetology: trends of diabetic nephropathy in diabetes. Nephrologie & Therapeutique. 2006;2(Suppl 3):S190–S192. - PubMed
-
- Stitt AW, Jenkins AJ, Cooper ME. Advanced glycation end products and diabetic complications. Expert Opinion in Investigational Drugs. 2002;11:1205–1223. - PubMed
-
- Rossing P. Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitus. Diabetic Medicine. 1998;15:900–919. - PubMed
-
- Navarro JF, Mora C, Maca M, Garca J. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. American Journal of Kidney Diseases. 2003;42:53–61. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
